Harris Erik
CIK: 0001780113•EVP & Chief Commercial Officer
OfficerDirector
Primary company: Ultragenyx Pharmaceutical Inc. (RARE)
Harris Erik is a corporate insider (EVP & Chief Commercial Officer) at Ultragenyx Pharmaceutical Inc. (RARE) filing SEC Form 4 transactions. 54 transactions across 4 companies, totaling $0 in purchases and $2,419,007 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 49,960 | $24.52 | $1.23M | 49,960 | 4/16/2026 Filed: 4/20/2026 | Filing → | |
| Award | 28,895 | - | - | 118,410 | 4/16/2026 Filed: 4/20/2026 | Filing → | |
Rezolute, Inc. RZLT | Award | 12,000 | - | - | 12,000 | 11/19/2025 Filed: 11/21/2025 | Filing → |
Rezolute, Inc. RZLT | Award | 21,000 | - | - | 21,000 | 11/19/2025 Filed: 11/21/2025 | Filing → |
Rezolute, Inc. RZLT | Award | 60,000 | $2.89 | $173K | 60,000 | 3/25/2025 Filed: 3/26/2025 | Filing → |
| Sale | 15,103 | $42.10 | $636K | 87,855 | 3/3/2025 Filed: 3/4/2025 | Filing → | |
| Award | 30,246 | $42.92 | $1.30M | 30,246 | 3/1/2025 Filed: 3/4/2025 | Filing → | |
| Award | 18,443 | - | - | 102,419 | 3/1/2025 Filed: 3/4/2025 | Filing → | |
| Award | 16,813 | - | - | 83,976 | 3/1/2025 Filed: 3/4/2025 | Filing → | |
Inozyme Pharma, Inc. INZY | Award | 56,000 | - | - | 56,000 | 10/3/2024 Filed: 10/7/2024 | Filing → |
| Award | 17,901 | - | - | 17,901 | 5/31/2024 Filed: 6/4/2024 | Filing → | |
| Award | 5,967 | - | - | 17,052 | 5/31/2024 Filed: 6/4/2024 | Filing → | |
| Award | 34,200 | - | - | 34,200 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Sale | 4,768 | $53.76 | $256K | 67,163 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Award | 957 | - | - | 71,638 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Award | 19,400 | - | - | 70,681 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
| Sale | 6,000 | $37.96 | $228K | 51,281 | 9/5/2023 Filed: 9/6/2023 | Filing → | |
| Sale | 305 | $48.20 | $15K | 57,281 | 6/19/2023 Filed: 6/21/2023 | Filing → | |
| Award | 12,649 | $0.00 | $0 | 12,649 | 6/1/2023 Filed: 6/5/2023 | Filing → | |
| Award | 4,216 | $0.00 | $0 | 11,085 | 6/1/2023 Filed: 6/5/2023 | Filing → |
Type
Award
Shares
49,960
Price
$24.52
Value
$1.23M
Type
Award
Shares
28,895
Price
-
Value
-
Rezolute, Inc.
RZLT
Type
Award
Shares
12,000
Price
-
Value
-
Rezolute, Inc.
RZLT
Type
Award
Shares
21,000
Price
-
Value
-
Rezolute, Inc.
RZLT
Type
Award
Shares
60,000
Price
$2.89
Value
$173K
Type
Sale
Shares
15,103
Price
$42.10
Value
$636K
Type
Award
Shares
30,246
Price
$42.92
Value
$1.30M
Type
Award
Shares
18,443
Price
-
Value
-
Type
Award
Shares
16,813
Price
-
Value
-
Inozyme Pharma, Inc.
INZY
Type
Award
Shares
56,000
Price
-
Value
-
Type
Award
Shares
17,901
Price
-
Value
-
Type
Award
Shares
5,967
Price
-
Value
-
Type
Award
Shares
34,200
Price
-
Value
-
Type
Sale
Shares
4,768
Price
$53.76
Value
$256K
Type
Award
Shares
957
Price
-
Value
-
Type
Award
Shares
19,400
Price
-
Value
-
Type
Sale
Shares
6,000
Price
$37.96
Value
$228K
Type
Sale
Shares
305
Price
$48.20
Value
$15K
Type
Award
Shares
12,649
Price
$0.00
Value
$0
Type
Award
Shares
4,216
Price
$0.00
Value
$0
AI Agent
Try asking...